Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databases
-
Published:2024-06
Issue:
Volume:15
Page:78-83
-
ISSN:2666-3287
-
Container-title:JAAD International
-
language:en
-
Short-container-title:JAAD International
Author:
Feldman Steven R.ORCID,
Bohn Rhonda L.,
Gao Ran,
Gray Stephani,
Walton Sabrina E.,
Déruaz-Luyet Anouk,
Wu Jashin J.
Funder
Boehringer Ingelheim
Reference18 articles.
1. An update on generalized pustular psoriasis;Gooderham;Expert Rev Clin Immunol,2019
2. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia;Choon;Int J Dermatol,2014
3. Treatment options and goals for patients with generalized pustular psoriasis;Krueger;Am J Clin Dermatol,2022
4. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP;Fujita;J Dermatol,2018
5. Real-world biologic adherence, persistence, and monotherapy comparisons in US patients with psoriasis: results from IBM MarketScan® databases;Leonardi;Adv Ther,2022